November 18, 2026
Business

Lupin signs licensing pact with Galenicum Health for injectable Semaglutide(Soban News)

Lupin Atlantis Holdings SA (LAHSA) has entered into a partnership with Galenicum for finished formulations of injectable Semaglutide, a GLP-1 receptor agonist

​Lupin Atlantis Holdings SA (LAHSA) has entered into a partnership with Galenicum for finished formulations of injectable Semaglutide, a GLP-1 receptor agonist by Soban News (international And National News)

Related posts

Strategic expansion, digital & offline pharmacies driving growth: Dr Suneeta Reddy, Apollo Hospitals(Soban News)

News-Soban-Admin

Caliber Mining & Logistics IPO allotment today; GMP hints at 17% listing gain. Here’s how to check your status(Soban News)

News-Soban-Admin

‘Don’t like going out anymore’: Prithvi Shaw opens up on life and his goal of India comeback – The Times of India(Soban News)

News-Soban-Admin

Leave a Comment